Envista rebrands KaVo Imaging as DEXIS

Envista’s KaVo imaging business has been re-branded as “DEXIS”. Envista Holdings Corporation made the announcement that can be viewed as an extension of the DEXIS brand, known to dental professionals as a provider of digital intraoral radiography and diagnostic software innovation.

DEXIS now represents a complete portfolio of imaging and digital solutions including cone-beam computed tomography (CBCT), handheld x-rays, intraoral scanners, sensors, and navigated surgical solutions.

DEXIS will now join other imaging brands such as i-CAT, Gendex, Instrumentarium, SOREDEX, and NOMAD, many of which are pioneers in x-ray generation, digital intraoral radiography, panoramic and cephalometric imaging, and 3D CBCT imaging.

With over 150,000 imaging devices used in dental practices, Envista Holdings has one of the largest installed bases of dental imaging devices in the industry – in addition to their new diagnostics and treatment planning software suite DTX Studio.

“We are excited to unite our imaging portfolio under the DEXIS brand and unveil our new DEXIS logo that will be featured on our entire imaging portfolio,” said Amir Aghdaei, CEO, Envista Holdings Corporation.

“This is one step in our continued efforts to create integrated, digital workflows that connect all our products and enable dental professionals to treat and improve more patient lives.

“We are living out our strategy to digitize, personalize, and democratize dentistry and look forward to the future.”

DEXIS is an American company with presence in over 50 countries and employs a workforce approximately 1,000 employees. The imaging portfolio of KaVo will transition to DEXIS over the rest of 2022 with different schedules by product and region.

Envista is a global corporation of more than 30 dental brands, including Nobel Biocare, Ormco, and Kerr.